The Marcus (MCS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Second quarter 2024 revenue declined 15% year-over-year to $176 million, mainly due to weaker theatre performance and a less robust film slate, while hotels and resorts saw revenue growth but flat operating income due to higher depreciation.
Net loss for Q2 was $20.2 million, or $0.64 per share, impacted by $13.9–$15 million in debt conversion expense; excluding this, net loss was $5.2 million, or $0.17 per share.
Adjusted EBITDA for Q2 was $22 million, down from $38.7 million last year, reflecting lower theatre attendance and debt conversion expense.
Marcus Hotels & Resorts saw strong group demand and near pre-pandemic occupancy, while Marcus Theatres rebounded in June after a slow start due to prior Hollywood strikes.
Financial highlights
Q2 2024 revenues were $176 million (down from $207 million in Q2 2023); first half revenues were $314.6 million (down from $359.3 million).
Q2 operating income was $2.2 million (down from $20.8 million); first half operating loss was $14.4 million (down from $11.8 million income last year).
Hotel and resorts revenue grew 6.3% to $74.5 million in Q2; theatre revenue fell 25.9% to $101.5 million.
Comparable hotel RevPAR increased 6.5% year-over-year, with occupancy up 4.5 points to 72.7%.
Theatre attendance dropped 26.3% and admission revenue fell 28.8% year-over-year.
Outlook and guidance
Group hotel bookings for the remainder of 2024 are running 11% ahead of last year, and 2025 bookings are over 36% ahead.
Theatres expect a stronger second half of the year as film supply normalizes, with a robust slate for late 2024 and 2025.
Capital expenditures for 2024 are projected at $60–$75 million, with timing subject to project finalization.
Effective tax rate for 2024 expected in the 5–10% range, excluding one-time items.
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025